Crossref
Prognostic significance of PD-1, CTLA-4, CD4, and CD8 expression in olfactory neuroblastoma
Clinical Neuropathology · 2023
DOI: 10.5414/np301519 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Neuropathology, 2023. Verfasst von Linlin Wu und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Esthesioneuroblastoma, Olfactory, Nose Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Esthesioneuroblastoma, OlfactoryNose NeoplasmsHumansCD8-Positive T-LymphocytesPrognosisCTLA-4 AntigenProgrammed Cell Death 1 ReceptorNasal CavityB7-H1 AntigenTumor Microenvironment
Substanzen
CTLA-4 AntigenProgrammed Cell Death 1 ReceptorB7-H1 Antigen
Zitieren
APA
Wu, L., Liu, H., & Liu, H. (2023). Prognostic significance of PD-1, CTLA-4, CD4, and CD8 expression in olfactory neuroblastoma. Clinical Neuropathology. https://doi.org/10.5414/np301519
Vancouver
Wu L, Liu H, Liu H. Prognostic significance of PD-1, CTLA-4, CD4, and CD8 expression in olfactory neuroblastoma. Clinical Neuropathology. 2023. doi:10.5414/np301519
BibTeX
@article{Wu2023,
author = {Wu, Linlin and Liu, Hui and Liu, Honggang},
title = {Prognostic significance of PD-1, CTLA-4, CD4, and CD8 expression in olfactory neuroblastoma},
journal = {Clinical Neuropathology},
year = {2023},
doi = {10.5414/np301519}
}
EUVIMED